1. Home
  2. FULC vs BZUN Comparison

FULC vs BZUN Comparison

Compare FULC & BZUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FULC
  • BZUN
  • Stock Information
  • Founded
  • FULC 2015
  • BZUN 2007
  • Country
  • FULC United States
  • BZUN China
  • Employees
  • FULC N/A
  • BZUN N/A
  • Industry
  • FULC Biotechnology: Pharmaceutical Preparations
  • BZUN Catalog/Specialty Distribution
  • Sector
  • FULC Health Care
  • BZUN Consumer Discretionary
  • Exchange
  • FULC Nasdaq
  • BZUN Nasdaq
  • Market Cap
  • FULC 210.9M
  • BZUN 188.7M
  • IPO Year
  • FULC 2019
  • BZUN N/A
  • Fundamental
  • Price
  • FULC $2.90
  • BZUN $2.73
  • Analyst Decision
  • FULC Hold
  • BZUN Buy
  • Analyst Count
  • FULC 8
  • BZUN 2
  • Target Price
  • FULC $6.57
  • BZUN $3.20
  • AVG Volume (30 Days)
  • FULC 427.9K
  • BZUN 257.6K
  • Earning Date
  • FULC 05-12-2025
  • BZUN 03-20-2025
  • Dividend Yield
  • FULC N/A
  • BZUN N/A
  • EPS Growth
  • FULC N/A
  • BZUN N/A
  • EPS
  • FULC N/A
  • BZUN N/A
  • Revenue
  • FULC $80,000,000.00
  • BZUN $1,290,875,449.00
  • Revenue This Year
  • FULC N/A
  • BZUN $5.59
  • Revenue Next Year
  • FULC N/A
  • BZUN $4.40
  • P/E Ratio
  • FULC N/A
  • BZUN N/A
  • Revenue Growth
  • FULC 2752.05
  • BZUN 6.92
  • 52 Week Low
  • FULC $2.78
  • BZUN $2.11
  • 52 Week High
  • FULC $10.13
  • BZUN $4.38
  • Technical
  • Relative Strength Index (RSI)
  • FULC 37.74
  • BZUN 33.81
  • Support Level
  • FULC $3.00
  • BZUN $2.92
  • Resistance Level
  • FULC $3.35
  • BZUN $3.08
  • Average True Range (ATR)
  • FULC 0.18
  • BZUN 0.14
  • MACD
  • FULC 0.02
  • BZUN -0.06
  • Stochastic Oscillator
  • FULC 24.78
  • BZUN 4.83

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

About BZUN Baozun Inc.

Baozun Inc is an e-commerce service partner that helps brands execute their e-commerce strategies in China by selling their goods directly to customers online or by providing services to assist with their e-commerce operations. Its integrated end-to-end e-commerce service capabilities, omni-channel expertise, and technology-driven solutions. Company have two operating segments namely E-Commerce (including BEC and BZI) and Brand Management (BBM).

Share on Social Networks: